http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010510970-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010510970-A |
| titleOfInvention | Crystalline form of zoledronic acid |
| abstract | The present invention relates to novel crystalline forms of low water soluble salts of zoledronic acid, methods for preparing these crystalline forms, compositions containing these crystalline forms, and diagnostic or therapeutic treatments for warm-blooded animals, particularly humans Relates to the use of these crystal forms in The present invention relates to a crystalline monohydrate of zoledronic acid free acid, a method for preparing a crystalline monohydrate of zoledronic acid free acid, a composition containing the crystalline monohydrate of zoledronic acid free acid, and a The invention relates to the use of the free acid crystalline monohydrate of zoledronic acid in the diagnostic or therapeutic treatment of blood animals, especially humans. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016179952-A |
| priorityDate | 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.